An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Jim Cramer in a latest program mentioned an analyst downgrade on The J. M. Smucker Company (NYSE:SJM) and reiterated that he ...

Gypsy-Rose Blanchard denied the 'false rumor' that CPS paid a visit to her home out of concern for her baby daughter Aurora, ...

Eli Lilly (NYSE: LLY) sells many products across treatment areas, from immunology to neuroscience. The company sells ...

The biggest development in weight-loss medicine since bariatric surgery (not to ... Some of these access issues were ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Time for your weekly edition of the Defector Funbag. Got something on your mind? Email the Funbag. And buy Drew’s book, The ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...